Posted on 1/9/17
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Last year a handful of setbacks led shares of Regeneron Pharmaceuticals(NASDAQ:REGN) about 29% lower, while Pfizer (NYSE:PFE) stock ended 2016 about 2% higher than it began. . . .
Posted on 1/9/17
Will CVS Health Corporation Raise Its Dividend in 2017?
CVS Health Corporation (NYSE:CVS) shareholders have reason to be dismayed. The giant pharmacy services company's stock was pummeled in the second half of 2016. On the . . .
Posted on 1/9/17
Biogen's New CEO: Lots of Questions, Few Answers
Biogen (NASDAQ:BIIB) named Michel Vounatsos as CEO on Dec. 19, 2016. Just a few weeks later, Vounatsos had his first moment to shine at the Goldman . . .
Posted on 1/8/17
Ionis and Akcea Enter into Strategic Collaboration with Global Pharmaceutical Company
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) and Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceuticals, Inc., today announced an exclusive, worldwide option and collaboration agreement with Novartis . . .
Posted on 1/6/17
MC10 and UCB Complete Landmark Pharmaceutical / Technology Collaboration
LEXINGTON, Mass.--(BUSINESS WIRE)--MC10, Inc., the company pioneering conformal, body-worn computing systems, is excited to announce the successful completion of their innovative collaboration with global biopharmaceutical company . . .
Posted on 1/6/17
NeuroMetrix Closes $7.0 Million Private Placement
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced that it has closed its previously announced private placement to a healthcare dedicated institutional investor of 7,000 shares . . .
Posted on 1/5/17
Cerveau Technologies Signs License Agreement with Merck
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced finalization of an exclusive license agreement with Merck, known as MSD outside the US and Canada, for the global development . . .
Posted on 1/5/17
T2 Biosystems Announces $50M Credit Facility
LEXINGTON, Mass., Jan. 05, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve patient health and deliver a strong . . .
Posted on 1/5/17
Did Biogen Just Throw in the Towel to Celgene?
IMAGE SOURCE: KB3TRAINING.COM Specialty medicines are only used by 1-2% of the U.S. population, but they're downright costly. In fact, in 2015 specialty drugs represented 37% . . .
Posted on 1/5/17
Loxo Oncology Announces Proposed Public Offering of Common Stock
STAMFORD, Conn., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically . . .
Posted on 1/5/17
Paragonix Technologies Announces an Exclusive Supply Agreement with Sanbor Medical
BRAINTREE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced entering into a supply agreement with Sanbor Medical, LLC for the manufacture and assembly of SherpaPak™ Cardiac Transport System1,2 . . .
Posted on 1/3/17
Dunkin' Donuts Announces Plans To Develop Up To 69 New Restaurants In Louisiana
Dunkin' Donuts, America's all-day, everyday stop for coffee and baked goods, announced today that New Orleans Saints Quarterback Drew Brees, in partnership with existing franchisee Vik . . .
Posted on 1/3/17
Walsh Brothers Selected for North Shore Medical Center Salem Campus Project
Walsh Brothers, Incorporated announced today that Partners HealthCare and the North Shore Medical Center (NSMC) have selected the firm to perform construction management services for an . . .
Posted on 1/1/17
NeuroMetrix Announces $7.0 Million Private Placement
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in . . .
Posted on 1/1/17
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage developer of innovative RNA-targeted therapeutics, granted equity awards on December 30, 2016, that were previously approved by the . . .
Posted on 12/30/16
ProEx Physical Therapy Appoints Roger St. Onge as Physical Therapist
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces that Roger
Posted on 12/23/16
Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement
BOSTON, Mass., IRVINE, Calif., & REHOVOT, Israel--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ:TKAI) and Otic Pharma Ltd., a privately-held, clinical-stage pharmaceutical company focusing on the development and commercialization . . .
Posted on 12/22/16
Patterson Dental Extends Partnership with American Dental Partners
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies Inc. (Nasdaq: PDCO) today announced the extension of Patterson Dental's partnership with American Dental Partners (ADPI).ADPI, a leading provider of dental . . .
Posted on 12/22/16
Hallmark Health Joins Wellforce
MEDFORD, Mass.--(BUSINESS WIRE)--The Board of Trustees of Hallmark Health, the parent company of Melrose-Wakefield Hospital and Lawrence Memorial Hospital of Medford, today voted unanimously to finalize . . .
Posted on 12/22/16
Concert Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating CTP-656 for the Treatment of Cystic Fibrosis
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the initiation of a U.S.-based Phase 2 clinical trial evaluating CTP-656 (deuterated ivacaftor), a next generation CFTR . . .
Posted on 12/22/16
Peak Physical Therapy & Sports Performance Staff Volunteer at “A Cure in the Nick of Time” Road Race to Benefit Batten Disease Research
Peak Physical Therapy & Sports Performance Staff recently donated services to runners at the 2nd annual “A Cure in the Nick of Time” Road Race in . . .
Posted on 12/22/16
Will 2017 Be CVS Health Corporation's Worst Year Yet?
It's been a pretty rough year for CVS Health (NYSE:CVS). Even though the giant pharmacy services company beat earnings estimates in each of the first three . . .
Posted on 12/22/16
RXi Pharmaceuticals Closes $11.5 Million Underwritten Public Offering
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced the closing of its underwritten public offering . . .
Posted on 12/22/16
Sunovion Enters into License Agreement for Three Approved Treatment Options
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has entered into an exclusive license agreement with Novartis for the U.S. commercialization rights to three . . .
Posted on 12/22/16
OvaScience Announces Business Update
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced a business update. The . . .
Boston
